Skip to main content
Fig. 2 | Cancer Nanotechnology

Fig. 2

From: A combined miR-34a and arsenic trioxide nanodrug delivery system for synergistic inhibition of HCC progression after microwave ablation

Fig. 2

Characteristics of the As/miR34aNPs. A TEM images under different pH conditions. B Zeta potentials of As/miR34aNPs measured by DLS at different pH values. C Cell viability after treatment with blank nanoparticles was examined by MTT assay. D Drug release curves (pH 7.4 or pH 6.5, with or without GSH treatment). E miRNA agarose gel electrophoresis experiment. As/miR34aNPs were incubated with serum at different pH values for 24 h (pH 7.4 or pH 6.5, with or without GSH treatment)

Back to article page

Cancer Nanotechnology

ISSN: 1868-6966

Contact us